J. Berek

Most-cited papers

FIGO staging of endometrial cancer: 2023
J. Berek, X. Matías-Guiu, C. Creutzberg, C. Fotopoulou +5 more
2023International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics1,046 citations Open access
Semantic Scholar
Revised FIGO staging for carcinoma of the cervix uteri
N. Bhatla, J. Berek, Mauricio Cuello Fredes, L. Denny +24 more
2019International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics1,002 citations
Semantic Scholar
Cancer of the ovary, fallopian tube, and peritoneum: 2021 update
J. Berek, M. Renz, S. Kehoe, L. Kumar +1 more
2021International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics459 citations Open access
Semantic Scholar
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.
K. Moore, A. Secord, M. Geller, D. Miller +16 more
2019The Lancet Oncology421 citations
Semantic Scholar
Cancer of the ovary, fallopian tube, and peritoneum
J. Berek, Sean Kehoe, L. Kumar, M. Friedlander
2018International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics265 citations Open access
Semantic Scholar
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.
D. Armstrong, R. Alvarez, J. Bakkum-Gamez, L. Barroilhet +28 more
2019The Journal of the National Comprehensive Cancer Network248 citations Open access
Semantic Scholar
Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update
B. Andersen, C. Lacchetti, K. Ashing, J. Berek +8 more
2023Journal of Clinical Oncology246 citations Open access
Semantic Scholar
FIGO staging of endometrial cancer: 2023
J. Berek, Xavier Matias-Guiu, C. Creutzberg, C. Fotopoulou +5 more
2023Journal of Gynecologic Oncology234 citations Open access
Semantic Scholar
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial
J. D. del Campo, U. Matulonis, S. Malander, D. Provencher +17 more
2019Journal of Clinical Oncology165 citations Open access
Semantic Scholar
Germline Genetic Testing After Cancer Diagnosis.
A. Kurian, P. Abrahamse, A. Furgal, K. Ward +13 more
2023Journal of the American Medical Association (JAMA)155 citations Open access
Semantic Scholar
Greater Financial Toxicity Relates to Greater Distress and Worse Quality of Life Among Breast and Gynecologic Cancer Survivors
Catherine Benedict, Sophie Fisher, L. Schapira, Sabrina Chao +6 more
2021Psycho-Oncology112 citations Open access
Semantic Scholar
Gynecologic Cancer InterGroup consensus recommendations on clinical research in ovarian cancer
I. Vergote, A. González-Martín, D. Lorusso, C. Gourley +26 more
2022The Lancet Oncology106 citations Open access
Semantic Scholar
FIGO staging for carcinoma of the vulva: 2021 revision
A. Olawaiye, J. Cotler, Mauricio A. Cuello, N. Bhatla +6 more
2021International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics100 citations Open access
Semantic Scholar
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial.
A. Oza, U. Matulonis, S. Malander, S. Hudgens +16 more
2018The Lancet Oncology99 citations
Semantic Scholar
Commonly Occurring Cell Subsets in High-Grade Serous Ovarian Tumors Identified by Single-Cell Mass Cytometry
Veronica D. Gonzalez, N. Samusik, Tiffany J. Chen, Erica S. Savig +13 more
2018Cell Reports90 citations Open access
Semantic Scholar
Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019
A. Kurian, K. Ward, P. Abrahamse, Irina Bondarenko +6 more
2021Journal of Clinical Oncology88 citations Open access
Semantic Scholar
Cancer of the ovary, fallopian tube, and peritoneum: 2025 update
M. Renz, Michael L. Friedlander, J. Berek
2025International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics49 citations Open access
Semantic Scholar
2023 FIGO staging system for endometrial cancer: The evolution of the revolution.
David K. Gaffney, Xavier Matias-Guiu, D. Mutch, G. Scambia +4 more
2024Gynecologic Oncology47 citations Open access
Semantic Scholar
Long-term safety and secondary efficacy endpoints in the ENGOT-OV16/NOVA phase III trial of niraparib in recurrent ovarian cancer
U. Matulonis, J. Herrstedt, A. Oza, S. Mahner +15 more
2021Gynecologic Oncology45 citations
Semantic Scholar
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
W. Peters, P.-Y. Liu, R. Barrett, R. Stock +6 more
2023Journal of Clinical Oncology44 citations
Semantic Scholar
Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri
J. Berek, K. Matsuo, B. Grubbs, D. Gaffney +9 more
2018Journal of Gynecologic Oncology43 citations Open access
Semantic Scholar
Final overall survival and long-term safety in the ENGOT-OV16/NOVA phase III trial of niraparib in patients with recurrent ovarian cancer (LBA 6)
U. Matulonis, J. Herrstedt, A. Oza, S. Mahner +17 more
2023Gynecologic Oncology40 citations
Semantic Scholar
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study
Yeh-Chen Lee, M. King, R. O'Connell, A. Lanceley +18 more
2022International Journal of Gynecological Cancer35 citations Open access
Semantic Scholar
Development of Therapeutic Vaccines for Ovarian Cancer
S. Chow, J. Berek, O. Dorigo
2020Vaccines33 citations Open access
Semantic Scholar
QUADRA: A phase 2, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) who have received ≥3 prior chemotherapy regimens.
K. Moore, A. Secord, M. Geller, D. Miller +13 more
201832 citations
Semantic Scholar
Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).
F. Roncolato, D. Berton-Rigaud, R. O'Connell, A. Lanceley +15 more
2018Gynecologic Oncology29 citations Open access
Semantic Scholar
LONG-TERM FOLLOW-UP OF EFFICACY AND SAFETY OF SELINEXOR MAINTENANCE TREATMENT IN PATIENTS WITH TP53WT ADVANCED OR RECURRENT ENDOMETRIAL CANCER: A SUBGROUP ANALYSIS OF THE ENGOT-EN5/GOG-3055/SIENDO STUDY
V. Makker, J. Pérez-Fidalgo, G. Valabrega, Erika Hamilton +26 more
2024Gynecologic Oncology27 citations Open access
Semantic Scholar
FIGO statement: Fertility preservation
L. Henry, J. Berek, I. Diaz, D. Feldberg +9 more
2023International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics24 citations Open access
Semantic Scholar
FIGO position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy
Danielle Mor-Hadar, S. Wilailak, J. Berek, O. McNally
2024International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics23 citations Open access
Semantic Scholar
Impact of Mobile Technologies on Cervical Cancer Screening Practices in Lagos, Nigeria (mHealth-Cervix): A Randomized Controlled Trial
K. Okunade, A. Soibi-Harry, S. John-Olabode, A. Adejimi +9 more
2021JCO Global Oncology21 citations Open access
Semantic Scholar
Association of Genetic Testing Results with Mortality Among Women with Breast Cancer or Ovarian Cancer.
A. Kurian, P. Abrahamse, Irina Bondarenko, A. Hamilton +7 more
2021Journal of the National Cancer Institute19 citations Open access
Semantic Scholar
Changing cancer mindsets: A randomized controlled feasibility and efficacy trial
S. R. Zion, L. Schapira, J. Berek, D. Spiegel +2 more
2023Psycho-Oncology18 citations Open access
Semantic Scholar
Imaging and cancer of the cervix in low- and middle-income countries
Jeffrey D. Olpin, L. Chuang, J. Berek, David K. Gaffney
2018Gynecologic Oncology Reports18 citations Open access
Semantic Scholar
Cancer in pregnancy: FIGO Best practice advice and narrative review
Surabhi Nanda, Melanie Nana, L. Nguyen-Hoang, S. Adam +23 more
2025International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics17 citations Open access
Semantic Scholar
Changing Mindsets About Side Effects of the COVID-19 Vaccination: A Randomized Controlled Trial
Alia J. Crum, L. Heathcote, Zara Morrison, Rachael Yielder +6 more
2023Annals of Behavioral Medicine17 citations Open access
Semantic Scholar
Association of Illness Mindsets with Health-Related Quality of Life in Cancer Survivors
Anna Zeidman, Catherine Benedict, S. R. Zion, Sophie Fisher +6 more
2022Health Psychology17 citations Open access
Semantic Scholar
Impact of mobile technologies on cervical cancer screening practices in Lagos, Nigeria (mHealth-Cervix): Protocol for a randomised controlled trial
K. Okunade, O. Salako, A. Adejimi, O. Akinsola +7 more
2020F1000Research16 citations Open access
Semantic Scholar
ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety.
U. Matulonis, J. Herrstedt, A. Oza, S. Mahner +17 more
2025Gynecologic Oncology15 citations
Semantic Scholar
Response: FIGO staging of endometrial cancer: 2023
J. Berek, X. Matías-Guiu
2023International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics14 citations
Semantic Scholar
Management and Care of Patients With Invasive Cervical Cancer: ASCO Resource-Stratified Guideline Rapid Recommendation Update
L. Chuang, S. Temin, J. Berek
2022JCO Global Oncology14 citations Open access
Semantic Scholar
Examining associations among sexual health, unmet care needs, and distress in breast and gynecologic cancer survivors
Catherine Benedict, Sophie Fisher, Dhanya Kumar, E. Pollom +4 more
2022Seminars in Oncology Nursing13 citations Open access
Semantic Scholar
Predictors of Survival Outcomes After Primary Treatment of Epithelial Ovarian Cancer in Lagos, Nigeria
K. Okunade, A. Adejimi, Ephraim Ohazurike, O. Salako +8 more
2021JCO Global Oncology13 citations Open access
Semantic Scholar
A Revised Markov Model Evaluating Oophorectomy at the Time of Hysterectomy for Benign Indication: Age 65 Years Revisited.
W. Parker, Michael Broder, J. Berek, C. Farquhar +2 more
2022Obstetrics and Gynecology12 citations
Semantic Scholar
Cancer and fertility management: FIGO best practice advice
Nikhil C. Purandare, F. Ruiloba, L. Nguyen-Hoang, S. Wilailak +23 more
2025International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics11 citations Open access
Semantic Scholar
#161 Final overall survival and long-term safety in the ENGOT-OV16/NOVA phase 3 trial of niraparib in patients with recurrent ovarian cancer
M. Mirza, J. Herrstedt, A. Oza, S. Mahner +16 more
2023Oral Sessions10 citations Open access
Semantic Scholar
FIGO 2023 staging for endometrial cancer, when, if it is not now?
Xavier Matias-Guiu, Sigurd F. Lax, M. Raspollini, J. Palacios +12 more
2024European Journal of Cancer9 citations
Semantic Scholar
Impact of mobile health technologies on human papillomavirus vaccination uptake among mothers of unvaccinated girls aged 9–14 years in Lagos, Nigeria (mHealth-HPVac): study protocol of a randomised controlled trial
K. Okunade, A. Adejimi, T. Adekanye, Matthew J. Allsop +8 more
2024BMC Cancer9 citations Open access
Semantic Scholar
Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects
M. Mirza, G. Lindahl, S. Mahner, A. Redondo +16 more
2022Cancer Research Communications9 citations Open access
Semantic Scholar
Patterns of Social Media Use and Associations with Psychosocial Outcomes among Breast and Gynecologic Cancer Survivors
L. Tolby, Elisa N. Hofmeister, Sophie Fisher, Sabrina Chao +5 more
2020Journal of cancer survivorship9 citations Open access
Semantic Scholar
Safety and Efficacy Results of Retreatment With a PARP Inhibitor Monotherapy in Late-Line Recurrent Ovarian Cancer: Results From a Subset of the QUADRA Trial
B. Rimel, A. Secord, M. Geller, D. Miller +16 more
20209 citations
Semantic Scholar